
Opinion|Videos|November 17, 2023
Myelodysplastic Syndrome (MDS) Overview
Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
3
Top 5 Inflammation Articles of 2025
4
Top 5 Myasthenia Gravis Content of 2025
5








































